Nucleus

'Advisers trust us on James Hay deal', says Nucleus CEO

Nucleus profits cut by half during 2020

Shareholders to vote on Nucleus deal on March 30

‘I’ve been with Nucleus 14 years — here’s why I might leave’

Nucleus staff face cuts after James Hay deal

Nucleus scooped up by James Hay for £145m

Nucleus's IMX range uses ESG considerations

Nucleus rivals ‘overpriced’ DFMs with planning-led MPS

Transact pulls out of race to buy Nucleus

Transact FSCS levy rises 82% but firm eyes fee cut

Why private equity firms are buying platforms

Inflows double at Nucleus as latest acquisition completes

Transact and James Hay bids push Nucleus shares up 35%

Nucleus ‘not treading water’ with tech acquisition

Nucleus recoups pandemic losses

Nucleus introduces ad-hoc fees in efficiency push

Platform signatures still a sticking point for advisers

Advisers name their favourite platforms of 2020

Nucleus boss expects fees to fall by 33% in five years

Nucleus to invest £3m a year in tech as profits tumble